Literature DB >> 2159280

Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.

F R McKenzie1, G Milligan.   

Abstract

Mouse neuroblastoma x rat glioma hybrid cells (NG108-15) express an opioid receptor of the delta subclass which both stimulates high-affinity GTPase activity and inhibits adenylate cyclase by interacting with a pertussis-toxin-sensitive guanine-nucleotide-binding protein(s) (G-protein). Four such G-proteins have now been identified without photoreceptor-containing tissues. We have generated anti-peptide antisera against synthetic peptides which correspond to the C-terminal decapeptides of the alpha-subunit of each of these G-proteins and also to the stimulatory G-protein of the adenylate cyclase cascade (Gs). Using these antisera, we demonstrate the expression of three pertussis-toxin-sensitive G-proteins in these cells, which correspond to the products of the Gi2, Gi3 and Go genes, as well as Gs. Gi1, however, is not expressed in detectable amounts. IgG fractions from each of these antisera and from normal rabbit serum were used to attempt to interfere with the interaction of the opioid receptor with the G-protein system by assessing ligand stimulation of high-affinity GTPase activity, inhibition of adenylate cyclase activity and conversion of the receptor to a state which displays reduced affinity for agonists. The IgG fraction from the antiserum (AS7) which specifically identifies Gi2 in these cells attenuated the effects of the opioid receptor. This effect was complete and was not mimicked by any of the other antisera. We conclude that the delta-opioid receptor of these cells interacts directly and specifically with Gi2 to cause inhibition of adenylate cyclase, and that Gi2 represents the true Gi of the adenylate cyclase cascade. The ability to measure alterations in agonist affinity for receptors following the use of specific antisera against a range of G-proteins implies that such techniques should be applicable to investigations of the molecular identity of the G-protein(s) which interacts with any receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159280      PMCID: PMC1131301          DOI: 10.1042/bj2670391

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by alpha-adrenergic receptors. I. Inhibition of adenylate cyclase mediated by alpha receptors.

Authors:  S L Sabol; M Nirenberg
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

2.  Guanine-nucleotide-binding proteins expressed in rat white adipose tissue. Identification of both mRNAs and proteins corresponding to Gi1, Gi2 and Gi3.

Authors:  F M Mitchell; S L Griffiths; E D Saggerson; M D Houslay; J T Knowler; G Milligan
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

Review 3.  Tissue distribution and subcellular location of guanine nucleotide binding proteins: implications for cellular signalling.

Authors:  G Milligan
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

4.  The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.

Authors:  M D Houslay; J C Metcalfe; G B Warren; T R Hesketh; G A Smith
Journal:  Biochim Biophys Acta       Date:  1976-06-17

5.  Persistent activation of the alpha subunit of Gs promotes its removal from the plasma membrane.

Authors:  G Milligan; C G Unson
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

6.  Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis.

Authors:  G Koski; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

8.  ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity.

Authors:  T Katada; M Ui
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

9.  Changes in the anti-lipolytic action and binding to plasma membranes of N6-L-phenylisopropyladenosine in adipocytes from starved and hypothyroid rats.

Authors:  P Chohan; C Carpenter; E D Saggerson
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

10.  Reconstitution of resolved muscarinic cholinergic receptors with purified GTP-binding proteins.

Authors:  V A Florio; P C Sternweis
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

View more
  47 in total

1.  Measurement of agonist-induced guanine nucleotide turnover by the G-protein Gi1alpha when constrained within an alpha2A-adrenoceptor-Gi1alpha fusion protein.

Authors:  A Wise; I C Carr; G Milligan
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Gi3 does not contribute to the inhibition of adenylate cyclase when stimulation of an alpha 2-adrenergic receptor causes activation of both Gi2 and Gi3.

Authors:  S J McClue; E Selzer; M Freissmuth; G Milligan
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 3.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

4.  Asymmetrical distribution of G-proteins among the apical and basolateral membranes of rat enterocytes.

Authors:  N van den Berghe; N J Nieuwkoop; A B Vaandrager; H R de Jonge
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

5.  Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G-proteins.

Authors:  C W Fong; G Milligan
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

6.  Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells.

Authors:  G D Kim; I C Carr; G Milligan
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

7.  A constitutively active mutant of the alpha 1B-adrenergic receptor can cause greater agonist-dependent down-regulation of the G-proteins G9 alpha and G11 alpha than the wild-type receptor.

Authors:  T W Lee; A Wise; S Cotecchia; G Milligan
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

Review 8.  Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results.

Authors:  Y Sarne; A Fields; O Keren; M Gafni
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

9.  Comparison of the signalling properties of the long and short isoforms of the rat thyrotropin-releasing-hormone receptor following expression in rat 1 fibroblasts.

Authors:  T W Lee; L A Anderson; K A Eidne; G Milligan
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

Review 10.  Xanthine nucleotide-specific G-protein alpha-subunits: a novel approach for the analysis of G-protein-mediated signal transduction.

Authors:  Andreas Gille; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.